NOTV

Inotiv, Inc.
2 filings tracked
healthcarebiotechnologySMALL ($300M-2B)

Signal Magnitude Chart

BEARISH | 90% | 5/11/2026 | earnings missBEARISH | 70% | 5/11/2026 | dilution riskNEUTRAL | 60% | 5/11/2026 | debt restructureBEARISH | 50% | 5/11/2026 | margin compressionBEARISH | 90% | 5/11/2026 | earnings missBEARISH | 70% | 5/11/2026 | dilution riskNEUTRAL | 60% | 5/11/2026 | debt restructureBEARISH | 50% | 5/11/2026 | margin compressionMay 26May 26HIGHLOW
bullish
bearish
neutral

Signal Timeline

bearishMay 11

Consolidated net loss increased significantly to $60.8M for the first half of the year.

earnings miss
90%
bearishMay 11

Company is exploring recapitalization and restructuring to avoid insolvency.

dilution risk
70%
neutralMay 11

Management is pursuing strategic alternatives to address a $410M current debt load.

debt restructure
60%
bearishMay 11

RMS segment operating income swung from a profit to a loss due to volume declines.

margin compression
50%
bearishMay 11

Consolidated net loss increased significantly to $60.8M for the first half of the year.

earnings miss
90%
bearishMay 11

Company is exploring recapitalization and restructuring to avoid insolvency.

dilution risk
70%
neutralMay 11

Management is pursuing strategic alternatives to address a $410M current debt load.

debt restructure
60%
bearishMay 11

RMS segment operating income swung from a profit to a loss due to volume declines.

margin compression
50%